Key facts
- Medihive’s last known valuation is $62.0M (Dec 2024).
- It has raised $21.1M; the latest was Later Stage VC ($2.7M) in Dec 2024.
- Notable investors include Enterprise Ireland, Davycrest Nominees, Cyril McGuire, Irishman Brian McSweeney, ResMed — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Medihive
- ·The full record, as it builds
Funding rounds
No funding rounds for Medihive are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medihive
Developer of cloud-based digital health technology designed for enhancing care delivery and operational efficiency. The company's platform automates patient engagement, appointment scheduling, prescription management, and referral processing, while providing secure, centralized data management for clinical services and chronic care programs, enabling healthcare providers, pharmacies, and corporate employers to achieve measurable results through scalable, secure, and customized digital infrastructure.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2014
- Employees
- 79
- Website
- medihive.com/
- Ownership
- Privately Held (backing)
Medihive doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medihive shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medihive in its N-PORT filings yet. We sweep new filings monthly.